(Q55035311)

16 June 2018

title

Progressive Supranuclear Palsy. (English)

1 reference

16 June 2018

author name string

Lawrence I. Golbe

series ordinal

1

1 reference

16 June 2018

publication date

1 November 2001

1 reference

16 June 2018

Current treatment options in neurology

published in

1 reference

16 June 2018

volume

3

1 reference

16 June 2018

issue

6

1 reference

16 June 2018

page(s)

473-477

1 reference

16 June 2018

https://scigraph.springernature.com/pub.10.1007/s11940-001-0010-0

exact match

0 references

cites work

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0010-0

Risk factors for progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0010-0

Prevalence and natural history of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0010-0

Mutational analysis of the tau gene in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0010-0

Failure of cholinergic agonist RS-86 to improve cognition and movement in PSP despite effects on sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0010-0

Treatment of progressive supranuclear palsy with tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0010-0

Association of an extended haplotype in the tau gene with progressive supranuclear palsy

21 January 2018

1 reference

12 December 2020

Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy.

1 reference

12 December 2020

Progressive supranuclear palsy. Clinical and pharmacologic update

1 reference

12 December 2020

Pramipexole in progressive supranuclear palsy

1 reference

12 December 2020

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

1 reference

12 December 2020

Pharmacological Therapy in Progressive Supranuclear Palsy

1 reference

12 December 2020

Retrospective study of drug response in 87 patients with progressive supranuclear palsy

1 reference

12 December 2020

Progressive supranuclear palsy: clinical features and response to treatment in 16 patients

1 reference

12 December 2020

The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy

1 reference

12 December 2020

Treatment of Parkinson's Disease with Electroconvulsive Therapy

1 reference

12 December 2020

Progressive supranuclear palsy: clinical presentation and rehabilitation of two patients

1 reference

12 December 2020

Botulinum toxin-A improves the rigidity of progressive supranuclear palsy

1 reference

12 December 2020

Transparently blinded trials of methysergide

1 reference

12 December 2020

Autologous adrenal medullary transplant in progressive supranuclear palsy

1 reference

12 December 2020

Botulinum toxin treatment of apraxia of eyelid opening in progressive supranuclear palsy: report of two cases.

1 reference

12 December 2020

10.1007/S11940-001-0010-0

Identifiers

DOI

1 reference

16 June 2018

Dimensions Publication ID

1048208217

0 references

1 reference

16 June 2018